Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results

Publication Date

2026

Content Type

article

PubMed ID:

41337691

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS